Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
- PMID: 29035356
- DOI: "V体育2025版" 10.1038/nmat4997
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Abstract
An effective blood-based method for the diagnosis and prognosis of hepatocellular carcinoma (HCC) has not yet been developed. Circulating tumour DNA (ctDNA) carrying cancer-specific genetic and epigenetic aberrations may enable a noninvasive 'liquid biopsy' for diagnosis and monitoring of cancer. Here, we identified an HCC-specific methylation marker panel by comparing HCC tissue and normal blood leukocytes and showed that methylation profiles of HCC tumour DNA and matched plasma ctDNA are highly correlated. Using cfDNA samples from a large cohort of 1,098 HCC patients and 835 normal controls, we constructed a diagnostic prediction model that showed high diagnostic specificity and sensitivity (P < 0 VSports手机版. 001) and was highly correlated with tumour burden, treatment response, and stage. Additionally, we constructed a prognostic prediction model that effectively predicted prognosis and survival (P < 0. 001). Together, these findings demonstrate in a large clinical cohort the utility of ctDNA methylation markers in the diagnosis, surveillance, and prognosis of HCC. .
Comment in
-
Cell-free DNA: Treasure trove for cancer medicine.Nat Mater. 2017 Oct 25;16(11):1056-1057. doi: 10.1038/nmat5019. Nat Mater. 2017. PMID: 29066831 No abstract available.
"VSports app下载" Publication types
- "VSports" Actions
- "V体育平台登录" Actions
MeSH terms (VSports手机版)
- Actions (VSports手机版)
- "V体育2025版" Actions
- Actions (V体育安卓版)
- V体育官网入口 - Actions
- Actions (V体育安卓版)
- Actions (V体育安卓版)
- V体育官网入口 - Actions
"VSports最新版本" Substances
- "VSports最新版本" Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
